CLASS II Drug recall · Reported 2 May 2018 · FDA Enforcement Report

Lipo-plex Injectable- MDV Coastal Meds LLC 1759 Medical recalled

Coastal Meds is recalling Lipo-plex Injectable- MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532, distributed nationwide in the US. The recall was initiated on 5 Apr 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots: LP/100617 Discard by 4/4/2018; LP/101817 Discard by 4/16/2018; LP/103117 Discard by 4/29/2018; LP/110817 Discard by 5/7/2018; LP/111617 Discard by 5/15/2018; LP/120617 Discard by 6/4/2018; LP/120817 Discard by 6/6/2018; LP/121417 Discard by 6/12/2018; LP/010918 Discard by 7/8/2018; LP/011818 Discard by 07/17/2018; LP/012518 Discard by 7/24/2018; LP/020818 Discard by 8/7/2018; LP/021618 Discard by 8/15/2018; CALP/021218 Discard by 4/13/2018
Quantity recalled8099 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0724-2018
FDA event ID
79671
Recalling firm
Coastal Meds, Biloxi, MS
Classification
Class II
Status
Terminated
Recall initiated
5 Apr 2018
FDA classified
9 May 2018
Reported
2 May 2018
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Particulate Matter

Timeline

5 Apr 2018Recall initiated by company
2 May 2018Published in enforcement report+27 days
9 May 2018Classified by FDA+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate matter. Recall due to presence of unknown particulate matter.

Product as listed by the FDA

LIPO-PLEX Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Presence of Particulate matter. Recall due to presence of unknown particulate matter.

Which lots are affected?

Lots: LP/100617 Discard by 4/4/2018; LP/101817 Discard by 4/16/2018; LP/103117 Discard by 4/29/2018; LP/110817 Discard by 5/7/2018; LP/111617 Discard by 5/15/2018; LP/120617 Discard by 6/4/2018; LP/120817 Discard by 6/6/2018; LP/121417 Discard by 6/12/2018; LP/010918 Discard by 7/8/2018; LP/011818 Discard by 07/17/2018; LP/012518 Discard by 7/24/2018; LP/020818 Discard by 8/7/2018; LP/021618 Discard by 8/15/2018; CALP/021218 Discard by 4/13/2018

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

9 other products · FDA event 79671

This product is part of a recall event; the main page for the event is Lipo-b Injectable- MDV Coastal Meds LLC 1759 Medical Park recalled.

More recalls from Coastal Meds

All 10